Clinical Evaluation of the miraDry System in Subjects With Hyperhidrosis

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether treatment by the miraDry System can safely reduce the severity of axillary hyperhidrosis (excessive underarm sweating).

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01091129
Study type	Interventional
Source	Miramar Labs
Contact
Status	Completed
Phase	N/A
Start date	February 2010
Completion date	January 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04546438` - Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis	N/A
Completed	`NCT03836287` - Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)	Phase 3
Enrolling by invitation	`NCT02105753` - Tx Axillary Hyperhidrosis 1210nm Diode Laser	N/A
Withdrawn	`NCT05546710` - miraDry Post Market Tumescent Anesthesia Study	N/A
Active, not recruiting	`NCT02295891` - Miradry Treatment for Focal Axillary Hyperhidrosis	N/A
Completed	`NCT01118429` - Use of Oxybutynin to Treat Axillary Hyperhidrosis	N/A
Completed	`NCT03948646` - Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)	Phase 3
Completed	`NCT01274611` - Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)	N/A
Completed	`NCT03320096` - Evaluation of the Ulthera System for Treating Axillary Hyperhidrosis	N/A
Completed	`NCT00735293` - VASER Treatment of Axillary Hyperhidrosis/Bromidrosis	Phase 4